Nuclear localisation of glutathione S-transferase π is an evaluation factor for drug resistance in gynaecological cancers

Clinical Oncology

Volumn 17, Issue 4, 2005, Pages 264-270

  Soh, Yoko ^a   Goto, S ^a   Kitajima, M ^a   Moriyama, S ^a   Kotera, K ^a   Nakayama, T ^a   Nakajima, H ^a   Kondo, T ^a   Ishimaru, T ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Drug resistance; Endometrial cancer; Glutathione S transferase ; Nuclear localisation; Ovarian cancer; Uterine cervical cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE TRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; CYTOREDUCTIVE SURGERY; ENDOMETRIUM CANCER; ENZYME ANALYSIS; ENZYME LOCALIZATION; FEMALE; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CELL NUCLEUS; CISPLATIN; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 19144372995     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.11.008     Document Type: Article

References (36)

1. F.M. Muggia Cisplatin update Semin Oncol 18 1991 1-4
2. W.P. McGuire W.J. Hoskins M.F. Brady et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1996 1-6
3. G. Coukos S.C. Rubin Chemotherapy resistance in ovarian cancer: New molecular perspectives [review] Obstet Gynecol 91 1998 783-792
4. R.P. Perez T.C. Hamilton R.F. Ozols et al. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer [review] Cancer 71 1993 1571-1580
5. B.A. Arrick C.F. Nathan Glutathione metabolism as a determinant of therapeutic efficacy: A review Cancer Res 44 1984 4224-4232
6. A. Meister On the discovery of glutathione Trends Biochem Sci 13 1988 185-188
7. W.R. Moore M.E. Anderson A. Meister et al. Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli: A possible model for mammalian cell protection Proc Natl Acad Sci U S A 86 1989 1461-1464
8. A.K. Godwin A. Meister P.J. O'Dwyer et al. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis Proc Natl Acad Sci U S A 89 1992 3070-3074
9. W.B. Jakoby The glutathione S-transferases: A group of multifunctional detoxification proteins Adv Enzymol Relat Areas Mol Biol 46 1978 383-414
10. L.F. Chasseaud The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents Adv Cancer Res 29 1979 175-274
11. J.R. Prohaska H.E. Ganther Glutathione peroxidase activity of glutathione-S-transferases purified from rat liver Biochem Biophys Res Commun 76 1977 437-445
12. M. Ujihara S. Tsuchida K. Satoh et al. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2a formation from prostaglandin H2 by various rat glutathione S-transferase isozymes Arch Biochem Biophys 264 1988 428-437
13. G. Batist A. Tulpule B.K. Sinha et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells J Biol Chem 261 1986 15544-15549
14. S. Hirata T. Odajima G. Kohama et al. Significance of glutathione S-transferase-π as a tumor marker in patients with oral cancer Cancer 70 1992 2381-2387
15. K. Satoh A. Kitahara Y. Soma et al. Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis Proc Natl Acad Sci U S A 82 1985 3964-3968
16. S. Hamada M. Kamada H. Furumoto et al. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy Gynecol Oncol 52 1994 313-319
17. Y. Saburi M. Nakagawa M. Ono et al. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum (II)-resistant variants of a Chinese hamster ovary cell line Cancer Res 49 1989 7020-7025
18. G. Batist A. Tulpule B.K. Sinha et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells J Biol Chem 261 1986 15544-15549
19. C.N. Robson A.D. Lewis C.R. Wolf et al. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity Cancer Res 47 1987 6022-6027
20. A.G. Hall A.G. McGuckin A.D. Pearson et al. Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma J Clin Pathol 47 1994 468-469
21. F. Ali-Osman J.M. Brunner T.M. Kutluk et al. Prognostic significance of glutathione S-transferase π expression and subcellular localization in human gliomas Clin Cancer Res 3 1997 2253-2261
22. S. Goto K. Kamada Y. Soh et al. Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs Jpn J Cancer Res 93 2002 1047-1056
23. S. Goto Y. Ihara Y. Urata et al. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase π FASEB J 15 2001 2702-2714
24. A.G. Van der Zee H.H. Hollema H.W. de Bruijn et al. Cell biological markers of drug resistance in ovarian carcinoma [review] Gynecol Oncol 58 1995 165-178
25. Y. Ohishi Y. Oda T. Uchiumi et al. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma Clin Cancer Res 8 2002 3767-3775
26. H.J. Arts D. Katsaros E.G. de Vries et al. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma Clin Cancer Res 5 1999 2798-2805
27. S. Kamazawa J. Kigawa Y. Kanamori et al. Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer Gynecol Oncol 86 2002 171-176
28. G.J. Rustin Use of CA-125 to assess response to new agents in ovarian cancer trials J Clin Oncol 21 2003 187-193
29. H. Itamochi J. Kigawa T. Sugiyama et al. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary Obstet Gynecol 100 2002 281-287
30. Y. Shiratori Y. Soma H. Maruyama et al. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neo-plastic human uterine cervix lesions Cancer Res 47 1987 6806-6809
31. B.J. Randall B. Angus R. Akiba et al. Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: An immunohistochemical study Br J Cancer 62 1990 614-618
32. H. Mukhtar E. Bresnick Glutathione-S-epoxide transferase activity during development and the effect of partial hepatectomy Cancer Res 36 1976 937-940
33. C. Kodate A. Fukushi T. Narita et al. Human placental form of glutathione S-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma Jpn J Cancer Res 77 1986 226-229
34. G. Clifton N. Kaplowitz The glutathione S-transferases of the small intestine in the rat Cancer Res 37 1977 788-791
35. B.A. Arrick C.F. Nathan Glutathione metabolism as a determinant of therapeutic efficacy: A review Cancer Res 44 1984 4224-4232
36. J. Huang P.H. Tan J. Thiyagarajan et al. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer Mod Pathol 16 2003 558-565